10-Q/A: FutureFuel Corp. Restates Q2 2023 Financials Due to Cash Flow Errors

FutureFuel Corp. has filed an amended 10-Q report to correct errors in its previously issued statement of cash flows for the second quarter of 2023, also impacting the full year 2023 and Q3 2023 reports.

Summary

• FutureFuel Corp. has restated its financial statements for the second quarter of 2023 due to errors in the statement of cash flows.
• The errors primarily affected the reported amounts of 'Other assets' and 'Collateralization of derivative instruments', impacting net cash flows from operating and investing activities.
• The restatement does not impact the company's overall cash position, balance sheets, statements of operations, or statements of stockholders' equity.
• The company identified a material weakness in its internal control over financial reporting as of June 30, 2023, related to the review of cash flows from investments.
• FutureFuel is implementing additional review procedures to enhance internal control over financial reporting.
• The company's revenue for the three months ended June 30, 2023, was $85.3 million, a decrease of 28% compared to the same period in 2022.
• The company reported a net loss of $9.9 million for the three months ended June 30, 2023, compared to a net loss of $3.1 million in the same period of 2022.
• For the six months ended June 30, 2023, revenue was $159.5 million, a slight decrease of 0.4% compared to the same period in 2022.
• The company reported a net income of $11.2 million for the six months ended June 30, 2023, compared to a net loss of $15.5 million in the same period of 2022.
• The company held 11.8 million RINs (Renewable Identification Numbers) with a fair market value of $19.5 million as of June 30, 2023, which were sold in July.

Sentiment

Score: 4

Explanation: The document reveals significant issues including a restatement of financials, a material weakness in internal controls, and a net loss for the quarter. While there are some positive aspects, the overall tone is negative due to the identified problems.

Positives

• The company's net income for the six months ended June 30, 2023, was $11.2 million, a significant improvement compared to a net loss of $15.5 million in the same period of 2022.
• Gross profit for the chemical segment improved due to stronger volumes and favorable product mix.
• The company's adjusted EBITDA for the six months ended June 30, 2023, was $8.6 million, a significant improvement compared to a loss of $8.2 million in the same period of 2022.
• The company sold all marketable securities in the three months ended June 30, 2023, realizing a gain of $575,000 for the six month period.
• Biofuel segment sales volumes increased 4.9% for the six months ended June 30, 2023.

Negatives

• The company experienced a net loss of $9.9 million for the three months ended June 30, 2023.
• Q2 2023 revenue decreased by 28% year-over-year to $85.3 million.
• A material weakness in internal control over financial reporting was identified as of June 30, 2023.
• Biofuel segment sales volume decreased 11% in the three months ended June 30, 2023.
• The company's gross loss for the three months ended June 30, 2023, was $8.6 million.

Risks

• The company identified a material weakness in its internal control over financial reporting, which could lead to future misstatements.
• The company's biofuel segment is subject to market volatility and fluctuations in RIN prices.
• The company's reliance on a few major customers in the biofuel segment poses a risk if those relationships change.
• The company's derivative strategy is subject to market volatility and can impact results.
• The company's effective tax rate can fluctuate based on the assessment of deferred tax assets.

Future Outlook

The company believes that existing cash balances, cash flow from operations, and borrowing capacity will be sufficient to fund operations, product development, cash dividends, and capital requirements for the foreseeable future.

Management Comments

• Management believes that the diversity of each segment strengthens the company in the ability to utilize resources and is committed to growing each segment.
• Management has reassessed its evaluation of the effectiveness of its internal control over financial reporting as of June 30, 2023 and concluded that a material weakness existed and that internal control over financial reporting was not effective as of June 30, 2023.

Industry Context

The company operates in the biofuels and specialty chemicals industries, which are subject to regulatory changes, commodity price fluctuations, and market demand shifts. The restatement highlights the importance of robust internal controls in these dynamic sectors.

Comparison to Industry Standards

• FutureFuel's restatement of cash flow statements is unusual and indicates a weakness in internal controls compared to industry best practices.
• Companies like Renewable Energy Group (REGI) and Darling Ingredients (DAR) in the biofuels sector typically have more robust financial reporting processes.
• In the specialty chemicals sector, companies like Albemarle (ALB) and Eastman Chemical (EMN) are known for their strong internal controls and consistent financial reporting.
• The material weakness identified in FutureFuel's internal controls is a concern, as it suggests a higher risk of future reporting errors compared to industry peers.

Corporate Governance

Legal Proceedings

• The company continues to dispute the February 2021 natural gas bill, and payment thereof is pending further investigation.

Related Party Transactions

• The company engages in transactions with companies affiliated with or controlled by a director and significant shareholder, with related party revenues, expenses, prepaid amounts, and unpaid amounts captured in the financial statements.

Stakeholder Impact

• Shareholders may be concerned about the restatement and the identified material weakness in internal controls.
• Employees may be affected by the company's efforts to remediate the internal control issues.
• Customers and suppliers may be impacted by any changes in the company's operations or financial stability.
• Creditors may be concerned about the company's financial performance and internal control issues.

Next Steps

• The company is implementing additional review procedures to enhance internal control over financial reporting.
• The company intends to file amendments to its 2023 Annual Report and Q3 2023 Quarterly Report to correct similar errors.

Key Dates

Keywords

restatement, financial statements, cash flow, internal control, material weakness, biofuel, chemicals, RINs, EBITDA, derivative instruments